量子位 · QbitAI

分子之心 AI drug discovery progress: 18 successes in 19 projects

The report highlights progress by 分子之心 in challenging antibody design and claims accuracy twice that of AlphaFold 3. It also presents results from AI-driven drug discovery work: 18 of 19 projects were successful, and hits were reported for all six GPCR targets.

Source published: Brief prepared:
分子之心 AI drug discovery progress: 18 successes in 19 projects
Image source · 量子位 · QbitAI

What to know

  • 01

    The report cites success in 18 of 19 projects and hits for all six GPCR targets.

  • 02

    分子之心 is described as achieving results in challenging antibody design, with claimed accuracy twice that of AlphaFold 3.

Why it matters

These reported results offer a reference point for tracking AI applications in antibody design and GPCR-target research.

Original sourceRead the source · 量子位 · QbitAIwww.qbitai.com

AI-assisted brief. Read the source for full details. Editorial & sourcing policy